Phenotype and Clinical Outcomes of Titin Cardiomyopathy

Improved understanding of dilated cardiomyopathy (DCM) due to titin truncation (TTNtv) may help guide patient stratification. The purpose of this study was to establish relationships among TTNtv genotype, cardiac phenotype, and outcomes in DCM. In this prospective, observational cohort study, DCM pa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2017-10, Vol.70 (18), p.2264-2274
Hauptverfasser: Tayal, Upasana, Newsome, Simon, Buchan, Rachel, Whiffin, Nicola, Halliday, Brian, Lota, Amrit, Roberts, Angharad, Baksi, A. John, Voges, Inga, Midwinter, Will, Wilk, Alijca, Govind, Risha, Walsh, Roddy, Daubeney, Piers, Jarman, Julian W.E., Baruah, Resham, Frenneaux, Michael, Barton, Paul J., Pennell, Dudley, Ware, James S., Prasad, Sanjay K., Cook, Stuart A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2274
container_issue 18
container_start_page 2264
container_title Journal of the American College of Cardiology
container_volume 70
creator Tayal, Upasana
Newsome, Simon
Buchan, Rachel
Whiffin, Nicola
Halliday, Brian
Lota, Amrit
Roberts, Angharad
Baksi, A. John
Voges, Inga
Midwinter, Will
Wilk, Alijca
Govind, Risha
Walsh, Roddy
Daubeney, Piers
Jarman, Julian W.E.
Baruah, Resham
Frenneaux, Michael
Barton, Paul J.
Pennell, Dudley
Ware, James S.
Prasad, Sanjay K.
Cook, Stuart A.
description Improved understanding of dilated cardiomyopathy (DCM) due to titin truncation (TTNtv) may help guide patient stratification. The purpose of this study was to establish relationships among TTNtv genotype, cardiac phenotype, and outcomes in DCM. In this prospective, observational cohort study, DCM patients underwent clinical evaluation, late gadolinium enhancement cardiovascular magnetic resonance, TTN sequencing, and adjudicated follow-up blinded to genotype for the primary composite endpoint of cardiovascular death, and major arrhythmic and major heart failure events. Of 716 subjects recruited (mean age 53.5 ± 14.3 years; 469 men [65.5%]; 577 [80.6%] New York Heart Association function class I/II), 83 (11.6%) had TTNtv. Patients with TTNtv were younger at enrollment (49.0 years vs. 54.1 years; p = 0.002) and had lower indexed left ventricular mass (5.1 g/m2 reduction; padjusted = 0.03) compared with patients without TTNtv. There was no difference in biventricular ejection fraction between TTNtv+/− groups. Overall, 78 of 604 patients (12.9%) met the primary endpoint (median follow-up 3.9 years; interquartile range: 2.0 to 5.8 years), including 9 of 71 patients with TTNtv (12.7%) and 69 of 533 (12.9%) without. There was no difference in the composite primary outcome of cardiovascular death, heart failure, or arrhythmic events, for patients with or without TTNtv (hazard ratio adjusted for primary endpoint: 0.92 [95% confidence interval: 0.45 to 1.87]; p = 0.82). In this large, prospective, genotype-phenotype study of ambulatory DCM patients, we show that prognostic factors for all-cause DCM also predict outcome in TTNtv DCM, and that TTNtv DCM does not appear to be associated with worse medium-term prognosis. [Display omitted]
doi_str_mv 10.1016/j.jacc.2017.08.063
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5666113</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0735109717394731</els_id><sourcerecordid>1957474399</sourcerecordid><originalsourceid>FETCH-LOGICAL-c549t-8dce6089c612d35ecd84df98728053e95241d2b724d5e4ed105f383d517fa4443</originalsourceid><addsrcrecordid>eNp9kc2KFDEQx4Mo7rj6Ah6kwYuXbvPZSUCEZfALFtbDeg7ZpNpJ052MSffCvI3P4pOZcdZFPXiqQ_3qR1X9EXpOcEcw6V-P3Wid6ygmssOqwz17gDZECNUyoeVDtMGSiZZgLc_Qk1JGjHGviH6MzqiuLS3EBqnPO4hpOeyhsdE32ynE4OzUXK2LSzOUJg3NdVhC_PF9a7MPaT6kvV12h6fo0WCnAs_u6jn68v7d9fZje3n14dP24rJ1guulVd5Bj5V2PaGeCXBecT9oJanCgoEWlBNPbyTlXgAHT7AYmGJeEDlYzjk7R29P3v16M0O1xSXbyexzmG0-mGSD-bsTw858TbdG9H1PCKuCV3eCnL6tUBYzh-JgmmyEtBZDtJBccqZ1RV_-g45pzbGe94tSlaNHIT1RLqdSMgz3yxBsjsGY0RyDMcdgDFamBlOHXvx5xv3I7yQq8OYEQH3mbYBsigsQHfiQwS3Gp_A__0-KIp8u</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1957874723</pqid></control><display><type>article</type><title>Phenotype and Clinical Outcomes of Titin Cardiomyopathy</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Tayal, Upasana ; Newsome, Simon ; Buchan, Rachel ; Whiffin, Nicola ; Halliday, Brian ; Lota, Amrit ; Roberts, Angharad ; Baksi, A. John ; Voges, Inga ; Midwinter, Will ; Wilk, Alijca ; Govind, Risha ; Walsh, Roddy ; Daubeney, Piers ; Jarman, Julian W.E. ; Baruah, Resham ; Frenneaux, Michael ; Barton, Paul J. ; Pennell, Dudley ; Ware, James S. ; Prasad, Sanjay K. ; Cook, Stuart A.</creator><creatorcontrib>Tayal, Upasana ; Newsome, Simon ; Buchan, Rachel ; Whiffin, Nicola ; Halliday, Brian ; Lota, Amrit ; Roberts, Angharad ; Baksi, A. John ; Voges, Inga ; Midwinter, Will ; Wilk, Alijca ; Govind, Risha ; Walsh, Roddy ; Daubeney, Piers ; Jarman, Julian W.E. ; Baruah, Resham ; Frenneaux, Michael ; Barton, Paul J. ; Pennell, Dudley ; Ware, James S. ; Prasad, Sanjay K. ; Cook, Stuart A.</creatorcontrib><description>Improved understanding of dilated cardiomyopathy (DCM) due to titin truncation (TTNtv) may help guide patient stratification. The purpose of this study was to establish relationships among TTNtv genotype, cardiac phenotype, and outcomes in DCM. In this prospective, observational cohort study, DCM patients underwent clinical evaluation, late gadolinium enhancement cardiovascular magnetic resonance, TTN sequencing, and adjudicated follow-up blinded to genotype for the primary composite endpoint of cardiovascular death, and major arrhythmic and major heart failure events. Of 716 subjects recruited (mean age 53.5 ± 14.3 years; 469 men [65.5%]; 577 [80.6%] New York Heart Association function class I/II), 83 (11.6%) had TTNtv. Patients with TTNtv were younger at enrollment (49.0 years vs. 54.1 years; p = 0.002) and had lower indexed left ventricular mass (5.1 g/m2 reduction; padjusted = 0.03) compared with patients without TTNtv. There was no difference in biventricular ejection fraction between TTNtv+/− groups. Overall, 78 of 604 patients (12.9%) met the primary endpoint (median follow-up 3.9 years; interquartile range: 2.0 to 5.8 years), including 9 of 71 patients with TTNtv (12.7%) and 69 of 533 (12.9%) without. There was no difference in the composite primary outcome of cardiovascular death, heart failure, or arrhythmic events, for patients with or without TTNtv (hazard ratio adjusted for primary endpoint: 0.92 [95% confidence interval: 0.45 to 1.87]; p = 0.82). In this large, prospective, genotype-phenotype study of ambulatory DCM patients, we show that prognostic factors for all-cause DCM also predict outcome in TTNtv DCM, and that TTNtv DCM does not appear to be associated with worse medium-term prognosis. [Display omitted]</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/j.jacc.2017.08.063</identifier><identifier>PMID: 29073955</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Alcohol ; Cardiac arrhythmia ; Cardiology ; Cardiomyopathy ; Cardiomyopathy, Dilated - diagnostic imaging ; Cardiomyopathy, Dilated - genetics ; Cardiovascular disease ; Child ; Clinical outcomes ; CMR ; Cohort Studies ; Confidence intervals ; Connectin ; Connectin - genetics ; Coronary vessels ; DCM ; Deoxyribonucleic acid ; Dilated cardiomyopathy ; DNA ; Enrollments ; Female ; Follow-Up Studies ; Gadolinium ; genetics ; Heart ; Heart attacks ; Heart diseases ; Heart failure ; Hospitals ; Humans ; Hypertension ; Magnetic resonance ; Male ; Middle Aged ; Mortality ; Mutation ; Patients ; Phenotype ; Prospective Studies ; Proteins ; Single-Blind Method ; titin ; Treatment Outcome ; Ventricle ; Young Adult</subject><ispartof>Journal of the American College of Cardiology, 2017-10, Vol.70 (18), p.2264-2274</ispartof><rights>2017 The Authors</rights><rights>Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Limited Oct 31, 2017</rights><rights>2017 The Authors 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c549t-8dce6089c612d35ecd84df98728053e95241d2b724d5e4ed105f383d517fa4443</citedby><cites>FETCH-LOGICAL-c549t-8dce6089c612d35ecd84df98728053e95241d2b724d5e4ed105f383d517fa4443</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0735109717394731$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29073955$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tayal, Upasana</creatorcontrib><creatorcontrib>Newsome, Simon</creatorcontrib><creatorcontrib>Buchan, Rachel</creatorcontrib><creatorcontrib>Whiffin, Nicola</creatorcontrib><creatorcontrib>Halliday, Brian</creatorcontrib><creatorcontrib>Lota, Amrit</creatorcontrib><creatorcontrib>Roberts, Angharad</creatorcontrib><creatorcontrib>Baksi, A. John</creatorcontrib><creatorcontrib>Voges, Inga</creatorcontrib><creatorcontrib>Midwinter, Will</creatorcontrib><creatorcontrib>Wilk, Alijca</creatorcontrib><creatorcontrib>Govind, Risha</creatorcontrib><creatorcontrib>Walsh, Roddy</creatorcontrib><creatorcontrib>Daubeney, Piers</creatorcontrib><creatorcontrib>Jarman, Julian W.E.</creatorcontrib><creatorcontrib>Baruah, Resham</creatorcontrib><creatorcontrib>Frenneaux, Michael</creatorcontrib><creatorcontrib>Barton, Paul J.</creatorcontrib><creatorcontrib>Pennell, Dudley</creatorcontrib><creatorcontrib>Ware, James S.</creatorcontrib><creatorcontrib>Prasad, Sanjay K.</creatorcontrib><creatorcontrib>Cook, Stuart A.</creatorcontrib><title>Phenotype and Clinical Outcomes of Titin Cardiomyopathy</title><title>Journal of the American College of Cardiology</title><addtitle>J Am Coll Cardiol</addtitle><description>Improved understanding of dilated cardiomyopathy (DCM) due to titin truncation (TTNtv) may help guide patient stratification. The purpose of this study was to establish relationships among TTNtv genotype, cardiac phenotype, and outcomes in DCM. In this prospective, observational cohort study, DCM patients underwent clinical evaluation, late gadolinium enhancement cardiovascular magnetic resonance, TTN sequencing, and adjudicated follow-up blinded to genotype for the primary composite endpoint of cardiovascular death, and major arrhythmic and major heart failure events. Of 716 subjects recruited (mean age 53.5 ± 14.3 years; 469 men [65.5%]; 577 [80.6%] New York Heart Association function class I/II), 83 (11.6%) had TTNtv. Patients with TTNtv were younger at enrollment (49.0 years vs. 54.1 years; p = 0.002) and had lower indexed left ventricular mass (5.1 g/m2 reduction; padjusted = 0.03) compared with patients without TTNtv. There was no difference in biventricular ejection fraction between TTNtv+/− groups. Overall, 78 of 604 patients (12.9%) met the primary endpoint (median follow-up 3.9 years; interquartile range: 2.0 to 5.8 years), including 9 of 71 patients with TTNtv (12.7%) and 69 of 533 (12.9%) without. There was no difference in the composite primary outcome of cardiovascular death, heart failure, or arrhythmic events, for patients with or without TTNtv (hazard ratio adjusted for primary endpoint: 0.92 [95% confidence interval: 0.45 to 1.87]; p = 0.82). In this large, prospective, genotype-phenotype study of ambulatory DCM patients, we show that prognostic factors for all-cause DCM also predict outcome in TTNtv DCM, and that TTNtv DCM does not appear to be associated with worse medium-term prognosis. [Display omitted]</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Alcohol</subject><subject>Cardiac arrhythmia</subject><subject>Cardiology</subject><subject>Cardiomyopathy</subject><subject>Cardiomyopathy, Dilated - diagnostic imaging</subject><subject>Cardiomyopathy, Dilated - genetics</subject><subject>Cardiovascular disease</subject><subject>Child</subject><subject>Clinical outcomes</subject><subject>CMR</subject><subject>Cohort Studies</subject><subject>Confidence intervals</subject><subject>Connectin</subject><subject>Connectin - genetics</subject><subject>Coronary vessels</subject><subject>DCM</subject><subject>Deoxyribonucleic acid</subject><subject>Dilated cardiomyopathy</subject><subject>DNA</subject><subject>Enrollments</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Gadolinium</subject><subject>genetics</subject><subject>Heart</subject><subject>Heart attacks</subject><subject>Heart diseases</subject><subject>Heart failure</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Magnetic resonance</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Mutation</subject><subject>Patients</subject><subject>Phenotype</subject><subject>Prospective Studies</subject><subject>Proteins</subject><subject>Single-Blind Method</subject><subject>titin</subject><subject>Treatment Outcome</subject><subject>Ventricle</subject><subject>Young Adult</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc2KFDEQx4Mo7rj6Ah6kwYuXbvPZSUCEZfALFtbDeg7ZpNpJ052MSffCvI3P4pOZcdZFPXiqQ_3qR1X9EXpOcEcw6V-P3Wid6ygmssOqwz17gDZECNUyoeVDtMGSiZZgLc_Qk1JGjHGviH6MzqiuLS3EBqnPO4hpOeyhsdE32ynE4OzUXK2LSzOUJg3NdVhC_PF9a7MPaT6kvV12h6fo0WCnAs_u6jn68v7d9fZje3n14dP24rJ1guulVd5Bj5V2PaGeCXBecT9oJanCgoEWlBNPbyTlXgAHT7AYmGJeEDlYzjk7R29P3v16M0O1xSXbyexzmG0-mGSD-bsTw858TbdG9H1PCKuCV3eCnL6tUBYzh-JgmmyEtBZDtJBccqZ1RV_-g45pzbGe94tSlaNHIT1RLqdSMgz3yxBsjsGY0RyDMcdgDFamBlOHXvx5xv3I7yQq8OYEQH3mbYBsigsQHfiQwS3Gp_A__0-KIp8u</recordid><startdate>20171031</startdate><enddate>20171031</enddate><creator>Tayal, Upasana</creator><creator>Newsome, Simon</creator><creator>Buchan, Rachel</creator><creator>Whiffin, Nicola</creator><creator>Halliday, Brian</creator><creator>Lota, Amrit</creator><creator>Roberts, Angharad</creator><creator>Baksi, A. John</creator><creator>Voges, Inga</creator><creator>Midwinter, Will</creator><creator>Wilk, Alijca</creator><creator>Govind, Risha</creator><creator>Walsh, Roddy</creator><creator>Daubeney, Piers</creator><creator>Jarman, Julian W.E.</creator><creator>Baruah, Resham</creator><creator>Frenneaux, Michael</creator><creator>Barton, Paul J.</creator><creator>Pennell, Dudley</creator><creator>Ware, James S.</creator><creator>Prasad, Sanjay K.</creator><creator>Cook, Stuart A.</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><general>Elsevier Biomedical</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20171031</creationdate><title>Phenotype and Clinical Outcomes of Titin Cardiomyopathy</title><author>Tayal, Upasana ; Newsome, Simon ; Buchan, Rachel ; Whiffin, Nicola ; Halliday, Brian ; Lota, Amrit ; Roberts, Angharad ; Baksi, A. John ; Voges, Inga ; Midwinter, Will ; Wilk, Alijca ; Govind, Risha ; Walsh, Roddy ; Daubeney, Piers ; Jarman, Julian W.E. ; Baruah, Resham ; Frenneaux, Michael ; Barton, Paul J. ; Pennell, Dudley ; Ware, James S. ; Prasad, Sanjay K. ; Cook, Stuart A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c549t-8dce6089c612d35ecd84df98728053e95241d2b724d5e4ed105f383d517fa4443</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Alcohol</topic><topic>Cardiac arrhythmia</topic><topic>Cardiology</topic><topic>Cardiomyopathy</topic><topic>Cardiomyopathy, Dilated - diagnostic imaging</topic><topic>Cardiomyopathy, Dilated - genetics</topic><topic>Cardiovascular disease</topic><topic>Child</topic><topic>Clinical outcomes</topic><topic>CMR</topic><topic>Cohort Studies</topic><topic>Confidence intervals</topic><topic>Connectin</topic><topic>Connectin - genetics</topic><topic>Coronary vessels</topic><topic>DCM</topic><topic>Deoxyribonucleic acid</topic><topic>Dilated cardiomyopathy</topic><topic>DNA</topic><topic>Enrollments</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Gadolinium</topic><topic>genetics</topic><topic>Heart</topic><topic>Heart attacks</topic><topic>Heart diseases</topic><topic>Heart failure</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Magnetic resonance</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Mutation</topic><topic>Patients</topic><topic>Phenotype</topic><topic>Prospective Studies</topic><topic>Proteins</topic><topic>Single-Blind Method</topic><topic>titin</topic><topic>Treatment Outcome</topic><topic>Ventricle</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tayal, Upasana</creatorcontrib><creatorcontrib>Newsome, Simon</creatorcontrib><creatorcontrib>Buchan, Rachel</creatorcontrib><creatorcontrib>Whiffin, Nicola</creatorcontrib><creatorcontrib>Halliday, Brian</creatorcontrib><creatorcontrib>Lota, Amrit</creatorcontrib><creatorcontrib>Roberts, Angharad</creatorcontrib><creatorcontrib>Baksi, A. John</creatorcontrib><creatorcontrib>Voges, Inga</creatorcontrib><creatorcontrib>Midwinter, Will</creatorcontrib><creatorcontrib>Wilk, Alijca</creatorcontrib><creatorcontrib>Govind, Risha</creatorcontrib><creatorcontrib>Walsh, Roddy</creatorcontrib><creatorcontrib>Daubeney, Piers</creatorcontrib><creatorcontrib>Jarman, Julian W.E.</creatorcontrib><creatorcontrib>Baruah, Resham</creatorcontrib><creatorcontrib>Frenneaux, Michael</creatorcontrib><creatorcontrib>Barton, Paul J.</creatorcontrib><creatorcontrib>Pennell, Dudley</creatorcontrib><creatorcontrib>Ware, James S.</creatorcontrib><creatorcontrib>Prasad, Sanjay K.</creatorcontrib><creatorcontrib>Cook, Stuart A.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tayal, Upasana</au><au>Newsome, Simon</au><au>Buchan, Rachel</au><au>Whiffin, Nicola</au><au>Halliday, Brian</au><au>Lota, Amrit</au><au>Roberts, Angharad</au><au>Baksi, A. John</au><au>Voges, Inga</au><au>Midwinter, Will</au><au>Wilk, Alijca</au><au>Govind, Risha</au><au>Walsh, Roddy</au><au>Daubeney, Piers</au><au>Jarman, Julian W.E.</au><au>Baruah, Resham</au><au>Frenneaux, Michael</au><au>Barton, Paul J.</au><au>Pennell, Dudley</au><au>Ware, James S.</au><au>Prasad, Sanjay K.</au><au>Cook, Stuart A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phenotype and Clinical Outcomes of Titin Cardiomyopathy</atitle><jtitle>Journal of the American College of Cardiology</jtitle><addtitle>J Am Coll Cardiol</addtitle><date>2017-10-31</date><risdate>2017</risdate><volume>70</volume><issue>18</issue><spage>2264</spage><epage>2274</epage><pages>2264-2274</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><abstract>Improved understanding of dilated cardiomyopathy (DCM) due to titin truncation (TTNtv) may help guide patient stratification. The purpose of this study was to establish relationships among TTNtv genotype, cardiac phenotype, and outcomes in DCM. In this prospective, observational cohort study, DCM patients underwent clinical evaluation, late gadolinium enhancement cardiovascular magnetic resonance, TTN sequencing, and adjudicated follow-up blinded to genotype for the primary composite endpoint of cardiovascular death, and major arrhythmic and major heart failure events. Of 716 subjects recruited (mean age 53.5 ± 14.3 years; 469 men [65.5%]; 577 [80.6%] New York Heart Association function class I/II), 83 (11.6%) had TTNtv. Patients with TTNtv were younger at enrollment (49.0 years vs. 54.1 years; p = 0.002) and had lower indexed left ventricular mass (5.1 g/m2 reduction; padjusted = 0.03) compared with patients without TTNtv. There was no difference in biventricular ejection fraction between TTNtv+/− groups. Overall, 78 of 604 patients (12.9%) met the primary endpoint (median follow-up 3.9 years; interquartile range: 2.0 to 5.8 years), including 9 of 71 patients with TTNtv (12.7%) and 69 of 533 (12.9%) without. There was no difference in the composite primary outcome of cardiovascular death, heart failure, or arrhythmic events, for patients with or without TTNtv (hazard ratio adjusted for primary endpoint: 0.92 [95% confidence interval: 0.45 to 1.87]; p = 0.82). In this large, prospective, genotype-phenotype study of ambulatory DCM patients, we show that prognostic factors for all-cause DCM also predict outcome in TTNtv DCM, and that TTNtv DCM does not appear to be associated with worse medium-term prognosis. [Display omitted]</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>29073955</pmid><doi>10.1016/j.jacc.2017.08.063</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0735-1097
ispartof Journal of the American College of Cardiology, 2017-10, Vol.70 (18), p.2264-2274
issn 0735-1097
1558-3597
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5666113
source MEDLINE; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Adolescent
Adult
Aged
Aged, 80 and over
Alcohol
Cardiac arrhythmia
Cardiology
Cardiomyopathy
Cardiomyopathy, Dilated - diagnostic imaging
Cardiomyopathy, Dilated - genetics
Cardiovascular disease
Child
Clinical outcomes
CMR
Cohort Studies
Confidence intervals
Connectin
Connectin - genetics
Coronary vessels
DCM
Deoxyribonucleic acid
Dilated cardiomyopathy
DNA
Enrollments
Female
Follow-Up Studies
Gadolinium
genetics
Heart
Heart attacks
Heart diseases
Heart failure
Hospitals
Humans
Hypertension
Magnetic resonance
Male
Middle Aged
Mortality
Mutation
Patients
Phenotype
Prospective Studies
Proteins
Single-Blind Method
titin
Treatment Outcome
Ventricle
Young Adult
title Phenotype and Clinical Outcomes of Titin Cardiomyopathy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T22%3A55%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phenotype%20and%20Clinical%20Outcomes%20of%20Titin%C2%A0Cardiomyopathy&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Tayal,%20Upasana&rft.date=2017-10-31&rft.volume=70&rft.issue=18&rft.spage=2264&rft.epage=2274&rft.pages=2264-2274&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/j.jacc.2017.08.063&rft_dat=%3Cproquest_pubme%3E1957474399%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1957874723&rft_id=info:pmid/29073955&rft_els_id=S0735109717394731&rfr_iscdi=true